| Quarter (USD) | Sep 24 | |
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Operating income | ||
| Operating margin | ||
| Net income | ||
| Net profit margin | ||
| Cash on hand | ||
| Change in cash | ||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 33.14 mm | |||||
| Cash burn (monthly) | 6.30 mm | |||||
| Cash used (since last report) | 25.33 mm | |||||
| Cash remaining | 7.81 mm | |||||
| Runway (months of cash) | 1.2 | |||||
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 16 Dec 24 | Allison Ambrose | Stock Option Common Stock | Grant | Acquire A | No | No | 19.01 | 100,000 | 1.90 mm | 100,000 |
| 15 Oct 24 | Wellington Biomedical Innovation Master Investors | Common Stock | Conversion | Acquire C | No | No | 0 | 894,733 | 0.00 | 894,733 |
| 15 Oct 24 | Wellington Biomedical Innovation Master Investors | Series B redeemable convertible preferred stock Common Stock | Conversion | Dispose C | No | No | 0 | 852,940 | 0.00 | 0 |
| 15 Oct 24 | Chimovits Erez | Common Stock | Buy | Acquire P | Yes | No | 17 | 660,000 | 11.22 mm | 4,554,873 |
| 15 Oct 24 | Chimovits Erez | Common Stock | Conversion | Acquire C | Yes | No | 0 | 2,887,833 | 0.00 | 3,894,873 |
| 15 Oct 24 | Chimovits Erez | Common Stock | Buy | Acquire P | Yes | No | 17 | 165,000 | 2.81 mm | 1,138,716 |
| 15 Oct 24 | Chimovits Erez | Common Stock | Conversion | Acquire C | Yes | No | 0 | 721,956 | 0.00 | 973,716 |
| 15 Oct 24 | Chimovits Erez | Series B redeemable convertible preferred stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 789,833 | 0.00 | 0 |
| 15 Oct 24 | Chimovits Erez | Series B redeemable convertible preferred stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 197,456 | 0.00 | 0 |
| 15 Oct 24 | Chimovits Erez | Series A redeemable convertible preferred stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 2,098,000 | 0.00 | 0 |
